ArticleSurgical endoscopy2025
Sleeve gastrectomy with same-day discharge: a propensity score-matched analysis of independent predictors of complication.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSleeve gastrectomy (SG) is the most performed bariatric surgery in the US, with a small but growing trend toward outpatient surgery. The aims of this study are to (1) clarify the safety of sleeve gastrectomy with same-day discharge (SDDSG) vs sleeve gastrectomy with inpatient stay (SGIS) utilizing recent MBSAQIP data, (2) identify specific predictors of complication in patients undergoing SDDSG, and (3) understand the relative uptake of SDDSG among the population for whom it would be low-risk.
methodsThis is a retrospective cohort study of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database. Cases of SDDSG and SGIS were identified in the 2021 and 2022 MBSAQIP. A 2:1 propensity score matching was conducted to control for baseline patient differences. Univariable analyses comparing complication with predictor variables were conducted using chi-square (categorical) or student's t-test (continuous). A stepwise multivariable model was performed to identify predictors of complications in SDDSG.
resultsThere were 28,235 cases of SDDSG, of which 406 (1.4%) experienced a complication vs 2.0% of SGIS (p < 0.001). Independent predictors of complication among those undergoing SDDSG included independent functional status (OR 0.24, p = 0.02), smoking status (OR 1.68, p = 0.003), previous cardiac surgery (OR 3.66, p = 0.005), and a history of venous thromboembolism requiring treatment (OR 2.67, p = 0.005). SDDSG accounted for 10.1% of all sleeve gastrectomies (SG), whereas 90.9% of all patients undergoing SG had none of the above risk factors.
conclusionSDDSG represents a potential pathway to reduce length of stay and cost for patients seeking bariatric surgery. Uptake remains low among the population at low risk for complication, with possible upside of reduced healthcare cost. When planning for SDDSG, clinicians should exercise patient-centered judgement, with careful consideration of an individual's risk profile.
Indexed as
Identifiers
40500544What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.